Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zymeworks (ZYME) Common Equity: 2021-2022

Historic Common Equity for Zymeworks (ZYME) over the last 2 years, with Dec 2022 value amounting to $493.0 million.

  • Zymeworks' Common Equity rose 136.06% to $424.3 million in Q3 2023 from the same period last year, while for Sep 2023 it was $424.3 million, marking a year-over-year increase of 136.06%. This contributed to the annual value of $493.0 million for FY2022, which is 97.90% up from last year.
  • As of FY2022, Zymeworks' Common Equity stood at $493.0 million, which was up 97.90% from $249.1 million recorded in FY2021.
  • In the past 5 years, Zymeworks' Common Equity ranged from a high of $493.0 million in FY2022 and a low of $249.1 million during FY2021.
  • Its 2-year average for Common Equity is $371.0 million, with a median of $371.0 million in 2021.
  • Data for Zymeworks' Common Equity shows a peak YoY surged of 97.90% (in 2022) over the last 5 years.
  • Yearly analysis of 2 years shows Zymeworks' Common Equity stood at $249.1 million in 2021, then soared by 97.90% to $493.0 million in 2022.